Facts
The French Cycling Federation (Fédération Française de Cyclisme, FFC) charges respondent M02 for a violation of the Anti-Doping Rules. During a cycling event on June 2, 2013, respondent provided a sample for doping test purposes. Analysis of the sample showed the presence of nikethamide and it's metabolites, tamoxifen and it's metabolites, 19-norandrosterone, a metabolite of nandrolone and a high testerone on epitestosterone ratio, a additional spectrometric analysis on isotopes showed testosterone of exogenous origin. Nikethamide, tamoxifen, nandrolone and exogenous testosterone are prohibited substances according the World Anti-Doping Agency (WADA) prohibited list.
History
The respondent had not intention to enhances his sport performance. He had used steroids to treat chronic hepatitis C which causes a joint complaint. He has certificates and reports to prove his condition. He admits he had made an error with the injections. For some substances he hadn't provide any explanation how they had entered his body.
The panel concludes that these products where used for an intentional effect on his sport performance.
Decision
1. The sanction is a period of ineligibility of three years in which respondent can't take part in competition or manifestations organized or authorized by French sport federations.
2. The period of ineligibility will be reduced by the period already served in: voluntary suspension, the decision of the disciplinary committee of the FFC (dated August 28, 2013) and the decision of the appeal committee of the FFC (dated September 30, 2013).
3. The decision of the appeal committee, dated September 30, 2013, should be modified
4. The decision starts on the date of notification.
5. The decision will be published and sent to the parties involved.
